6-KThe Wire
YD Bio Ltd files 6-K
Filed Jan 16, 2026 · 6mo ago · Accession 0001213900-26-004861
Plain English
YD Bio Limited announced changes to its Board of Directors, with four directors removed and two new directors elected, effective December 30, 2025. This action was taken via a shareholders' written consent from majority stockholders YD Biopharma Holding Limited and EG Biomed Limited.
Filing details
- Company
- YD Bio Ltd
- Ticker
- YDES
- CIK
- 2011674
- Form type
- 6-K
- Filing date
- Jan 16, 2026
- Report date
- Jan 16, 2026
- Document
- ea0273075-6k_ydbio.htm
- Size
- 11 KB